Triple-negative breast cancer (TNBC) tumors lack detectable estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) gene amplification (1). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.